BC
ARNA

Brookfield Corp’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Brookfield Corp’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-44,045
Closed -$2.62M – 770
2021
Q3 		$2.62M Buy
44,045
+4,122
+10% +$243K 0.01% 305
2021
Q2 		$2.72M Buy
39,923
+19,505
+96% +$1.27M 0.01% 306
2021
Q1 		$1.42M Buy
20,418
+6,053
+42% +$466K 0.01% 339
2020
Q4 		$1.1M Buy
14,365
+959
+7% +$71.9K ﹤0.01% 359
2020
Q3 		$1M Buy
13,406
+1,353
+11% +$90.2K 0.01% 301
2020
Q2 		$759K Buy
+12,053
New +$663K ﹤0.01% 301

Other funds holding ARNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Brookfield Corp's ARNA Position: Q4 2021 in Review

Brookfield Corp sold out of Arena Pharmaceuticals Inc (ARNA) in Q4 2021, closing a stake of 44,045 shares — an estimated $2.62M sold.

Brookfield Corp first reported a position in ARNA in Q2 2020 and held it in 6 quarters. The position peaked at $2.72M in Q2 2021. 317 funds tracked by Wall St. Rank hold ARNA as of Q4 2021.

  • Brookfield Corp reported no remaining Arena Pharmaceuticals Inc position as of Q4 2021 after selling out during the quarter.
  • Brookfield Corp sold 44,045 Arena Pharmaceuticals Inc shares in Q4 2021, an estimated $2.62M.
  • Brookfield Corp first reported a position in Arena Pharmaceuticals Inc in Q2 2020 and held it in 6 quarters.
  • Brookfield Corp's Arena Pharmaceuticals Inc position peaked at $2.72M in Q2 2021.
  • 317 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q4 2021.

Based on Brookfield Corp's 13F filing for Q4 2021, filed 14 Feb 2022.